The pooled result revealed that the expression of TP53 mutation was positive associated with the high‐stage bladder cancer compared with Ta stage (OR = 3.75; 95% CI, 2.50–5.63; p < 0.00001; Figure 2A). The gene discussed is TP53; the disease is urinary bladder carcinoma.